Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy()()

Weekly gemcitabine therapy is the major treatment offered for patients with pancreatic adenocarcinoma cancer; however, relative resistance of tumor cells to chemotherapy, rapid regrowth, and metastasis are the main causes of death within a year. Recently, the daily continuous administration of chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasnis, Erez, Alishekevitz, Dror, Gingis-Veltski, Svetlana, Bril, Rotem, Fremder, Ella, Voloshin, Tali, Raviv, Ziv, Karban, Amir, Shaked, Yuval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198746/
https://www.ncbi.nlm.nih.gov/pubmed/24957319
http://dx.doi.org/10.1016/j.neo.2014.05.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198746/
https://www.ncbi.nlm.nih.gov/pubmed/24957319
http://dx.doi.org/10.1016/j.neo.2014.05.011

Ejemplares similares